Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Public reporting and pay for performance in hospital quality improvement

Article Abstract:

An analysis of a national public-reporting initiative was conducted to evaluate whether combining pay for performance with public reporting results in improvement in quality of safety and health care in hospitals than public reporting alone. Results revealed that hospitals engaged in both public reporting and pay for performance achieved modest improvements in quality than those engaged only in public reporting.

Author: Rothberg, Michael B., Lindenauer, Peter K.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
Analysis, Reports, Medical care, Medical care quality, Pay for performance

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Public health response - assessing needs

Article Abstract:

The various health problems caused to the US population by the disastrous hurricane Katrina are discussed. The critical issues raised by Katrina's devastation are sanitation and hygiene, water safety, infection control, surveillance, immunizations, environmental health, and access to care, which need to be reconsidered to gain control.

Author: Greenough, P. Gregg, Kirsch, Thomas D.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2005
Health aspects, Care and treatment, Disaster victims, Hurricane Katrina, 2005

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Failing the public health- rofecoxib, Merck, and the FDA

Article Abstract:

The Food and Drug Administration (FDA) granted Merck approval to market rofecoxib, but neither Merck nor the FDA fulfilled their responsibility to the public. Millions of patients consuming rofecoxib are facing enormous public health issue and as a result the company withdrew the drug due to excess risk of myocardial infarctions.

Author: Topol, Eric J.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
Product development, Legal issues & crime, Government regulation (cont), Marketing procedures, Government regulation, Management dynamics, Pharmaceutical preparations, Alliances, partnerships, Licensing/Sales Agreements, Legal/Government Regulation, Management, Laws, regulations and rules, Pharmaceutical industry, Cooperative agreement for product marketing, Powers and duties, Company business management, United States. Food and Drug Administration, Rofecoxib, Merck & Company Inc., Marketing agreements

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Public health
Similar abstracts:
  • Abstracts: Plan B, reproductive rights and physician activism. Incontinence and the duty to provide care
  • Abstracts: Ensuring deafened patients can participate in their health care. Ensuring optimum uptake of influenza immunization
  • Abstracts: Dentists' participation and children's use of services in the Indiana dental Medicaid program and SCHIP. Teeth with large amalgam restorations and crowns
  • Abstracts: Health promotion programs may pay for themselves within 10 years: study. 2005 CEOs who 'get it'
  • Abstracts: Passive immunization during pregnancy for congenital cytomegalovirus infection. Hyperimmunoglobulin therapy for a twin fetus with cytomegalovirus infection and growth restriction
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.